Home » Newsletters » BioWorld Science

BioWorld Science

June 14, 2022

View Archived Issues

Teixobactin attenuates anthrax infection in a rabbit model

Loss-of-function mutations in ZFHX3 cause intellectual disability

Astrocyte-specific IL-2 delivery shows neuroprotective effect in four neuroinflammation models

Beijing Increase Innovation Drug Research divulges SGLT2 inhibitors

Roche discloses new HBV antivirals

Qilu Regor Therapeutics presents new STING antagonists

Fochon Pharmaceuticals identifies new BTK inhibitors

DA-1726 shows efficacy in diet-induced NASH mouse model

Chinese researchers disclose cardiac myosin inhibitors

Novel neurodevelopmental disorder associated with germline variants in FBXW7

Omadacycline, a promising treatment approach for chlamydial infections

NXP-900 shows tumor growth inhibition and survival benefit in mouse model of group 4 medulloblastoma

Alpha Cognition announces discovery of GEM combinations ALPHA-0702 and ALPHA-0802

Discovery of novel cathepsin C inhibitor with anti-inflammatory activity in vivo

Evotec and Janssen Pharmaceutica establish drug discovery collaboration

Hamlet and Neurochase partner to develop novel technology to deliver Alpha-1H for CNS tumors

EHA 2022 presentations describe sickle cell disease headway and headwinds

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 2, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...